Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
T-cell vaccines
antigen presentation
inflammation
lentiviral vaccine vectors
major histocompatibility complex
pre-existing anti-vector immunity
tropism for dendritic cells
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
05 Mar 2023
05 Mar 2023
Historique:
received:
08
02
2023
revised:
27
02
2023
accepted:
03
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Lentiviral vectors are among the most effective viral vectors for vaccination. In clear contrast to the reference adenoviral vectors, lentiviral vectors have a high potential for transducing dendritic cells in vivo. Within these cells, which are the most efficient at activating naive T cells, lentiviral vectors induce endogenous expression of transgenic antigens that directly access antigen presentation pathways without the need for external antigen capture or cross-presentation. Lentiviral vectors induce strong, robust, and long-lasting humoral, CD8
Identifiants
pubmed: 36986707
pii: pharmaceutics15030846
doi: 10.3390/pharmaceutics15030846
pmc: PMC10053212
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Virol. 2008 Jan;82(1):86-95
pubmed: 17959670
Hum Gene Ther. 2011 Feb;22(2):177-88
pubmed: 20825284
Virus Res. 2013 Sep;176(1-2):16-32
pubmed: 23796410
J Virol. 2004 May;78(10):5223-32
pubmed: 15113904
PLoS One. 2008;3(12):e3973
pubmed: 19096527
Nat Med. 2003 Jul;9(7):921-7
pubmed: 12808447
Proc Natl Acad Sci U S A. 2013 May 28;110(22):E2046-53
pubmed: 23580623
J Virol. 2009 Apr;83(7):3094-103
pubmed: 19176629
Nat Med. 2022 Jan;28(1):71-80
pubmed: 35075289
Cell. 2000 Apr 14;101(2):173-85
pubmed: 10786833
Immunol Rev. 2011 Jan;239(1):45-61
pubmed: 21198664
J Virol. 2007 Jan;81(2):539-47
pubmed: 17079284
Mol Ther. 2002 May;5(5 Pt 1):538-46
pubmed: 11991744
Commun Biol. 2021 Jun 10;4(1):713
pubmed: 34112936
Front Immunol. 2017 Oct 05;8:1262
pubmed: 29051764
Influenza Other Respir Viruses. 2019 Sep;13(5):429-437
pubmed: 31225704
Hum Gene Ther. 2005 Nov;16(11):1255-66
pubmed: 16259559
Vaccine. 2015 Sep 11;33(38):4798-806
pubmed: 26241951
Blood. 2010 Apr 15;115(15):3025-32
pubmed: 20130242
Nat Biotechnol. 2008 Mar;26(3):326-34
pubmed: 18297056
Nat Commun. 2018 Mar 12;9(1):1029
pubmed: 29531262
Viruses. 2021 Feb 23;13(2):
pubmed: 33672349
Blood. 2007 Apr 1;109(7):2797-805
pubmed: 17170119
Vaccine. 2010 Apr 30;28(20):3617-24
pubmed: 20051277
J Virol. 2015 Jun;89(12):6494-505
pubmed: 25855749
Vaccines (Basel). 2022 Sep 13;10(9):
pubmed: 36146594
Int J Cancer. 2013 Jan 15;132(2):335-44
pubmed: 22700466
J Immunol. 2009 May 15;182(10):5960-9
pubmed: 19414747
Mol Ther. 2022 Sep 7;30(9):2984-2997
pubmed: 35484842
J Virol. 2021 Sep 27;95(20):e0118021
pubmed: 34379511
Crit Rev Immunol. 2017;37(2-6):371-420
pubmed: 29773027
EMBO Mol Med. 2021 Dec 7;13(12):e14459
pubmed: 34647691
Sci Transl Med. 2021 Aug 18;13(607):
pubmed: 34315826
ACS Nano. 2021 Sep 28;15(9):14022-14048
pubmed: 34469112
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Virus Genes. 2017 Oct;53(5):723-732
pubmed: 28744797
Front Immunol. 2018 Feb 05;9:171
pubmed: 29459873
Mol Ther Methods Clin Dev. 2019 Jan 08;12:223-232
pubmed: 30775404
Blood. 2014 Feb 27;123(9):1422-4
pubmed: 24578496
Lancet. 2015 Jan 31;385(9966):453-65
pubmed: 25230594
Gene Ther. 2012 Dec;19(12):1133-40
pubmed: 22241177
Vaccines (Basel). 2022 Oct 28;10(11):
pubmed: 36366325
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288662
Nat Med. 2022 Jan;28(1):81-88
pubmed: 35075288
Blood. 2003 Apr 15;101(8):3058-64
pubmed: 12480693
Clin Cancer Res. 2006 May 15;12(10):3158-67
pubmed: 16707616
EMBO J. 2007 Jun 20;26(12):3025-37
pubmed: 17557080
Br J Haematol. 2000 Mar;108(4):817-24
pubmed: 10792288
J Immunother. 2017 Oct;40(8):302-306
pubmed: 28891906
Mol Ther Oncolytics. 2016 Mar 30;3:16010
pubmed: 27626061
J Virol. 2004 Mar;78(6):2906-20
pubmed: 14990709
Vaccine. 2010 Sep 24;28(41):6675-83
pubmed: 20709004
Gene Ther. 2010 Feb;17(2):150-7
pubmed: 19847206
J Virol. 2009 Nov;83(21):10963-74
pubmed: 19706700
J Immunol. 2014 Oct 15;193(8):4117-24
pubmed: 25217165
Mol Ther. 2010 Jan;18(1):80-6
pubmed: 19904234
Nat Rev Immunol. 2019 Sep;19(9):550-562
pubmed: 31114037
Cell Rep. 2022 Jul 26;40(4):111142
pubmed: 35905717
Cell Rep. 2019 Jan 29;26(5):1242-1257.e7
pubmed: 30699352
PLoS Negl Trop Dis. 2015 Oct 05;9(10):e0004081
pubmed: 26437302
Clin Cancer Res. 2019 Oct 1;25(19):5808-5817
pubmed: 31227504
J Virol. 2010 Jun;84(11):5627-36
pubmed: 20237085
Mol Ther. 2007 Jun;15(6):1203-10
pubmed: 17375069
J Mol Biol. 1994 Sep 2;241(5):651-62
pubmed: 7520946
Mol Ther. 2016 Nov;24(11):2021-2032
pubmed: 27455880
J Gene Med. 2006 Mar;8(3):265-74
pubmed: 16308885
Nat Microbiol. 2020 Jun;5(6):796-812
pubmed: 32367055
NPJ Vaccines. 2020 May 8;5(1):36
pubmed: 32411399
J Virol. 2012 May;86(9):5192-203
pubmed: 22345444
Mol Ther Methods Clin Dev. 2018 Aug 08;10:341-347
pubmed: 30191160
Mol Cell Biol. 1990 Aug;10(8):4239-42
pubmed: 2370865
Bioessays. 2007 May;29(5):452-64
pubmed: 17450595
Cell Host Microbe. 2021 Feb 10;29(2):236-249.e6
pubmed: 33357418
J Virol. 1992 Aug;66(8):4794-802
pubmed: 1629956
Gene Ther. 2020 Dec;27(12):545-556
pubmed: 32341484
N Engl J Med. 2003 Jan 16;348(3):255-6
pubmed: 12529469
Viral Immunol. 2006 Winter;19(4):690-701
pubmed: 17201664
NPJ Vaccines. 2020 Nov 18;5(1):107
pubmed: 33298954
J Clin Invest. 2003 Jun;111(11):1673-81
pubmed: 12782670
Hum Gene Ther. 2002 Jun 10;13(9):1091-100
pubmed: 12067442
Mucosal Immunol. 2022 Jun;15(6):1389-1404
pubmed: 36104497
J Virol. 2014 Feb;88(3):1492-501
pubmed: 24227853
Neurocrit Care. 2021 Jun;34(3):1062-1071
pubmed: 32661794
Vaccines (Basel). 2022 Dec 21;11(1):
pubmed: 36679857
Int J Mol Sci. 2020 May 21;21(10):
pubmed: 32455640
PLoS One. 2012;7(11):e48866
pubmed: 23139820
Mol Ther. 2007 Jul;15(7):1390-9
pubmed: 17505480
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7306-11
pubmed: 23589850
Leukemia. 2018 Jul;32(7):1529-1541
pubmed: 29654266
Biochem Soc Trans. 2003 Aug;31(Pt 4):748-52
pubmed: 12887296
BMC Immunol. 2008 Apr 15;9:15
pubmed: 18412969
J Clin Med. 2021 Aug 02;10(15):
pubmed: 34362224
Front Immunol. 2011 Oct 04;2:48
pubmed: 22566838
Mol Ther. 2020 Aug 5;28(8):1772-1782
pubmed: 32485138
Immunol Cell Biol. 2014 Jul;92(6):471-2
pubmed: 24777311
J Immunol. 2005 Mar 15;174(6):3808-17
pubmed: 15749922
Mol Ther. 2008 Aug;16(8):1427-36
pubmed: 18578012
Expert Rev Vaccines. 2021 Dec;20(12):1571-1586
pubmed: 34620025
J Virol. 2005 Sep;79(17):11547-51
pubmed: 16103210
Lancet. 2012 Nov 3;380(9853):1559-67
pubmed: 22975340
Gene Ther. 2003 Jun;10(11):935-40
pubmed: 12756413
J Immunol. 2004 Feb 1;172(3):1582-7
pubmed: 14734738
Science. 2003 Oct 17;302(5644):415-9
pubmed: 14564000
J Virol. 1992 May;66(5):2814-20
pubmed: 1560526
PLoS One. 2012;7(11):e48644
pubmed: 23133649
Virology. 1999 Aug 15;261(1):120-32
pubmed: 10441560
Int J Environ Res Public Health. 2018 Jan 09;15(1):
pubmed: 29315224
Med Sci (Paris). 2021 Dec;37(12):1172-1175
pubmed: 34928223
J Virol. 1998 Jun;72(6):5085-92
pubmed: 9573279
Cancer Res. 2006 Jan 15;66(2):1155-60
pubmed: 16424053
Annu Rev Immunol. 2018 Apr 26;36:279-308
pubmed: 29345964
PLoS One. 2013 Apr 23;8(4):e62684
pubmed: 23626846
J Pathol. 2020 Jul;251(3):228-248
pubmed: 32418199
BMC Biotechnol. 2009 Feb 16;9:10
pubmed: 19220915
Eur J Immunol. 2008 Jul;38(7):1867-76
pubmed: 18546142
Viruses. 2017 May 22;9(5):
pubmed: 28531165
Mol Ther. 2007 Sep;15(9):1716-23
pubmed: 17593926